- Generic name
- Sitagliptin
- Strength
- 50 mg
- Dosage form
- Tablet
- Manufactured by
- Biopharma Ltd.
Biogliptin 50 Tablet
About Biogliptin 50 Tablet
Made by Biopharma Ltd., Biogliptin 50 is a tablet whose active ingredient is Sitagliptin. Sitagliptin has not been studied in patients with a history of pancreatitis.
There are 21 brands of Sitagliptin listed in Bangladesh. The lowest listed price is Sitadus 25 mg Tablet at ৳ 8.03 per unit.
What is Biogliptin 50 Tablet?
The tablet Biogliptin 50 contains Sitagliptin and is made by Biopharma Ltd. The incretins are part of an endogenous system involved in the physiologic regulation of glucose homeostasis. Concentrations of the active intact hormones are increased by Sitagliptin, thereby increasing and prolonging the action of these hormones. The doctor decides the dose and course.
Uses of Biogliptin 50
Sitagliptin has not been studied in patients with a history of pancreatitis. Ask your doctor whether it is right for your condition.
How to use Biogliptin 50
Biogliptin 50 is taken by mouth. Swallow the tablet with water. Keep the tablets in a dry place away from light and heat, and out of the reach of children. Complete the course exactly as prescribed. If you miss a dose, ask your doctor or pharmacist what to do.
Side effects of Biogliptin 50
The most common adverse reactions include headache, upper respiratory tract infection and nasopharyngitis. Hypoglycemia may occur in patients treated with the combination to Sitagliptin and sulfonylurea and add on to insulin. Contact your doctor if you notice anything unusual after taking it. Tell your doctor if any side effect bothers you or does not go away.
Safety and precautions
Hypersensitivity Reactions : There have been post-marketing reports of serious hypersensitivity reactions in patients treated with Sitagliptin. If pancreatitis is suspected, Sitagliptin should promptly be discontinued and appropriate management should be initiated. Use in Patients with Renal Insufficiency : Dosage adjustment is recommended in patients with moderate or severe renal insufficiency and in patients with ESRD requiring hemodialysis or peritoneal dialysis. Keep out of reach of children.
Frequently asked questions
What does Biogliptin 50 treat?
Sitagliptin has not been studied in patients with a history of pancreatitis. Ask your doctor whether it is right for your condition.
How is Biogliptin 50 used?
Biogliptin 50 is taken by mouth. Swallow the tablet with water.
What should I watch for while using Biogliptin 50?
The most common adverse reactions include headache, upper respiratory tract infection and nasopharyngitis. Hypoglycemia may occur in patients treated with the combination to Sitagliptin and sulfonylurea and add on to insulin.
Who should be careful with Biogliptin 50?
Hypersensitivity Reactions : There have been post-marketing reports of serious hypersensitivity reactions in patients treated with Sitagliptin. If pancreatitis is suspected, Sitagliptin should promptly be discontinued and appropriate management should be initiated.
Indications
Important Limitations of Use: Sitagliptin should not be used in patients with type 1 diabetes ... Read moreMonotherapy and Combination Therapy: Sitagliptin is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
Important Limitations of Use: Sitagliptin should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis, as it would not be effective in these settings. Sitagliptin has not been studied in patients with a history of pancreatitis. It is unknown whether patients with a history of pancreatitis are at increased risk for the development of pancreatitis while using Sitagliptin.
Pharmacology
Dosage & Administration
Interaction
Digoxin: Sitagliptin slightly increases the mean of Digoxin concentration. However, no dose adjustment of either drug is required.
Contraindications
Side Effects
Pregnancy & Lactation
Precautions & Warnings
Use in Patients with Renal Insufficiency: Dosage adjustment is recommended in patients with moderate or severe renal insufficiency and in patients with ESRD requiring hemodialysis or peritoneal dialysis.
Use with medications known to cause Hypoglycemia: When sitagliptin is used in combination therapy dosage adjustment of sulfonylurea or insulin may be required to reduce the risk of hypoglycemia.
Hypersensitivity Reactions: There have been post-marketing reports of serious hypersensitivity reactions in patients treated with sitagliptin. These reactions include anaphylaxis, angioedema, and exfoliative skin conditions including Stevens-Johnson syndrome. If a hypersensitivity reaction is suspected, discontinue sitagliptin, assess for other potential causes for the event, and institute alternative treatment for diabetes.
Overdose Effects
In the event of an overdose, it is reasonable to employ the usual supportive measures, e.g., remove unabsorbed material from the gastrointestinal tract, employ clinical monitoring (including obtaining an electrocardiogram), and institute supportive therapy as dictated by the patient's clinical status. Sitagliptin is modestly dialyzable. In clinical studies, approximately 13.5% of the dose was removed over a 3- to 4-hour hemodialysis session. Prolonged hemodialysis may be considered if clinically appropriate. It is not known if sitagliptin is dialyzable by peritoneal dialysis.
Storage Conditions
Alternative brands of Sitagliptin
Other brands with the same generic name, cheapest first.
Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.